Neurodevelopmental outcomes after prenatal exposure to lamotrigine monotherapy in women with epilepsy: a systematic review and meta-analysis
Abstract Background Lamotrigine has become one of the most commonly prescribed antiseizure medications (ASM) in epileptic women during pregnancy and therefore requires regular updates regarding its safety. The aim of this study was to estimate the association between in utero exposure to lamotrigine...
Saved in:
Main Authors: | Audrey Peron (Author), Cyndie Picot (Author), Lucie Jurek (Author), Mikaïl Nourredine (Author), Emmanuelle Ripoche (Author), Priscilla Ajiji (Author), Michel Cucherat (Author), Judith Cottin (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical efficacy and safety of lamotrigine monotherapy in newly diagnosed pediatric patients with epilepsy
by: Ji Hye Han, et al.
Published: (2010) -
Lamotrigine (Lamictal) in Intractable Epilepsies
by: J Gordon Millichap
Published: (1997) -
Lamotrigine and Sudden Unexpected Death in Epilepsy
by: J Gordon Millichap
Published: (2007) -
Lamotrigine Open Trial in Refractory Epilepsy
by: J Gordon Millichap
Published: (1997) -
Investigating the efficacy and safety of metronidazole during pregnancy; A systematic review and meta-analysis
by: Priscilla Ajiji, et al.
Published: (2021)